葛均波，中國科學院院士、長江學者、教授、博士生導(dǎo)師。1993年畢業(yè)于德國美因茲大學，獲醫(yī)學博士學位。現(xiàn)任中國醫(yī)師協(xié)會心血管分會會長，中國心血管健康聯(lián)盟主席，復(fù)旦大學附屬中山醫(yī)院心內(nèi)科主任，上海市心血管臨床醫(yī)學中心主任，上海市心血管病研究所所長，復(fù)旦大學生物醫(yī)學研究院院長，復(fù)旦大學泛血管醫(yī)學研究院院長，教育部“心血管介入治療技術(shù)與器械”工程研究中心主任，美國心血管造影和介入學會理事會理事，美國心臟病學會國際顧問，世界心臟聯(lián)盟常務(wù)理事。

葛院士1987年起從事心血管疾病的臨床和科研工作，長期致力于冠狀動脈疾病診療策略的優(yōu)化與技術(shù)革新，在血管內(nèi)超聲技術(shù)、新型冠脈支架研發(fā)、復(fù)雜疑難冠脈疾病介入策略、冠脈疾病細胞治療等領(lǐng)域產(chǎn)生了一系列成果。先后承擔了20余項國家和省部級科研項目，參與多項國際多中心臨床研究項目，發(fā)表SCI或SCI-E收錄論文490余篇，主編英文專著1部、中文專著21部。獲得國家科技進步二等獎、國家技術(shù)發(fā)明獎二等獎、教育部科技進步一等獎等科技獎項10余項。

Ge Junbo, academician of the Chinese Academy of Sciences, Chang Jiang Scholar, professor and doctoral supervisor. In 1993, he graduated from the University of Mainz, Germany, and obtained the Doctor of Medicine degree. Academician Ge is the president of the Chinese Medical Doctor Association Cardiovascular Branch,president of the China Cardiovascular Health Alliance, director of the Department of Cardiology of Zhongshan Hospital Affiliated to Fudan University, director of the Shanghai Center for Cardiovascular Clinical Medicine,director of the Shanghai Institute of Cardiovascular Disease, president of the Biomedical Research Institute of Fudan University, president of the Fudan University Panvascular Medicine Institute, director of the Engineering Research Center of Interventional Cardiovascular Technology and Devices, Ministry of Education, council member of the American Society for Cardiovascular Angiography and Interventions, international advisor of the American College of Cardiology, and executive director of the World Heart Federation.

Academician Ge has been engaged in the clinical and scientific research of cardiovascular diseases since 1987.He has long been committed to the optimization and technological innovation of diagnosis and treatment strategies for coronary artery diseases. He has made a series of achievements in the fields of intravascular ultrasound technology, research and development of new coronary stents, intervention strategies for complex and difficult coronary diseases, and cell therapy for coronary diseases. He has undertaken more than 20 national and provincial scientific research projects, participated in a number of international multi-center clinical research projects,published more than 490 papers included in SCI or SCI-E, edited 1 monograph in English and 21 monographs in Chinese. He has won more than 10 scientific and technological awards, including the Second Prize of National Science and Technology Progress Award, the Second Prize of National Technological Invention Award, and the First Prize of Science and Technology Progress of the Ministry of Education.